PHK
ADMA icon

Point72 Hong Kong’s ADMA Biologics ADMA Stock Holding History

Point72 Hong Kong’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$101K Buy
+6,902
New +$118K ﹤0.01% 354
2021
Q2 		– Sell
-1,397
Closed -$2K – 1875
2021
Q1 		$2K Buy
+1,397
New +$3.2K ﹤0.01% 1703

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Hong Kong's ADMA Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in ADMA Biologics (ADMA) in Q3 2025: 6,902 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #354 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in ADMA as recently as Q1 2021.

Point72 Hong Kong first reported a position in ADMA in Q1 2021 and has held it in 2 quarters since. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Point72 Hong Kong held 6,902 shares of ADMA Biologics worth $101K as of Q3 2025.
  • ADMA Biologics was a new Point72 Hong Kong position in Q3 2025.
  • ADMA Biologics made up ﹤0.01% of Point72 Hong Kong's portfolio in Q3 2025, its #354 holding.
  • Point72 Hong Kong first reported a position in ADMA Biologics in Q1 2021 and has held it in 2 quarters since.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.